Biostatistics Practice Questions

Q: The variation in data is compared with another data set by:

Coefficient of variation. ***Coefficient of variation*** - The **coefficient of variation (CV)** is a standardized measure of dispersion of a probability distribution or frequency distribution. - It expresses the **standard deviation** as a percentage of the **mean**, making it useful for comparing the variability of two independent data sets with different units or widely different means. *Standard Error of Mean* - The **Standard Error of the Mean (SEM)** is used to estimate the variability between sample means if multiple samples were taken from the same population. - It primarily quantifies the accuracy with which a sample mean represents a population mean, not for comparing variations between different data sets. *Standard Deviation* - **Standard deviation (SD)** measures the amount of variation or dispersion of a set of values *within a single data set*. - While it quantifies variability, it is not ideal for directly comparing the variability of two data sets with different units or means because it isn't normalized. *Variance* - **Variance** measures how far each number in the set is from the mean; it is the **average of the squared differences** from the mean. - Like standard deviation, variance describes the spread within a single dataset and is not normalized for direct comparison between datasets with different scales.

Q: In the context of statistical analysis, if you have the value of one variable, which coefficient would you use to predict the value of another variable?

Coefficient of regression. ***Coefficient of regression*** - The **coefficient of regression** (or **regression coefficient**) is fundamental in **regression analysis**, which is specifically designed to predict the value of a **dependent variable** based on the value of one or more **independent variables**. - It quantifies the expected change in the dependent variable for a unit change in the independent variable. *Coefficient of variation* - The **coefficient of variation** is a measure of **relative variability** or dispersion, expressing the standard deviation as a percentage of the mean. - It describes the extent of variation in relation to the mean but does not provide a basis for predicting one variable from another. *Coefficient of correlation* - The **coefficient of correlation** measures the **strength and direction of a linear relationship** between two variables. - While it indicates how well two variables move together, it does not directly enable the prediction of one variable's value from another; that is the role of regression. *Coefficient of determination* - The **coefficient of determination (R²)** represents the **proportion of the variance** in the dependent variable that can be explained by the independent variable(s) in a regression model. - It quantifies how well the regression model fits the observed data, but it is not used directly for prediction; rather it is for assessing the predictive power of the model.

Q: Which measure indicates the diagnostic power of a test to correctly identify those with a disease?

Sensitivity. ***Positive predictive value*** - It refers to the probability that subjects with a positive test result truly have the disease, highlighting the test's **diagnostic accuracy** [1]. - A high positive predictive value indicates that the test is effective at diagnosing the disease in the population tested. *Sensitivity* - Sensitivity measures the ability of a test to correctly identify those with the disease (true positives), but does not account for the test result's predictive capability [1]. - It is important for screening, but **not directly the diagnostic power** for those already tested. *Negative predictive value* - This indicates the probability that subjects with a negative test result truly do not have the disease, focusing on true negatives rather than correct diagnosis of the condition [1]. - While informative, it does not assess the ability to correctly diagnose the disease when the result is positive. *Specificity* - Specificity is the measure of a test's ability to correctly identify those without the disease (true negatives), not diagnosing the disease accurately among those tested [1]. - It is essential for determining false positives but not for assessing the overall diagnostic power of a test. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 253-254.

Q: In a community of 1,000,000 population, 105 children were born in a year, out of which 5 were stillbirths and 4 died within the first year of life. What is the Infant Mortality Rate (IMR)?

40. ***40*** - **Infant Mortality Rate (IMR)** = (Deaths in first year of life / Live births) × 1,000 - Live births = Total births - Stillbirths = 105 - 5 = **100** - IMR = (4 / 100) × 1,000 = **40 per 1,000 live births** - Stillbirths are excluded from both numerator and denominator as IMR only counts deaths after live birth *90* - This would result from incorrectly using total births (105) instead of live births (100) in the denominator - Wrong calculation: (4 / 105) × 1,000 ≈ 38, not 90 - This option represents a common error but with incorrect arithmetic *120* - This could result from including stillbirths in the numerator: (5+4) / 100 × 1,000 = 90, not 120 - Or from other miscalculations mixing up the numerator and denominator - Does not follow the standard IMR formula *150* - This represents a significant calculation error - May result from using wrong base (per 100 instead of per 1,000) or including stillbirths incorrectly - Such high IMR does not match the given data of 4 infant deaths per 100 live births

Q: What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

They minimize selection bias.. ***They minimize selection bias.*** - **Randomization** in RCTs ensures that participants have an equal chance of being assigned to any of the treatment groups, thereby balancing potential **confounding factors** across groups. - This balance helps to ensure that any observed differences in outcomes between groups are more likely due to the intervention being studied rather than pre-existing differences among participants, thus minimizing **selection bias**. *They can be conducted more quickly than other study types.* - RCTs often require **extensive planning**, recruitment, and follow-up periods, making them one of the **most time-consuming** study designs. - The need for sufficient **power** to detect meaningful differences often translates into longer study durations. *They are ideal for studying rare diseases.* - Due to the requirement for **large sample sizes** to demonstrate statistical significance, RCTs are **not practical** for diseases with low prevalence. - Recruiting enough participants with a rare disease for an RCT can be extremely challenging and often **unfeasible**. *They are generally less expensive than other study types.* - RCTs are typically among the **most expensive** study designs because they involve extensive participant recruitment, intervention administration, data collection, and long-term follow-up. - The costs associated with staff, resources, and monitoring for ethical compliance contribute to their **high financial burden**.

Q: Bladder cancer can occur in those who are working in dye industry for 25 years. Which study design is most appropriate for establishing a causal relationship between dye industry work and bladder cancer?

Cohort study. ***Cohort study*** - A **cohort study** tracks a group of individuals exposed to a risk factor (dye industry work) and a group not exposed over time to see who develops the outcome (bladder cancer). - This design allows for the calculation of **incidence rates** and relative risk, which are crucial for establishing a causal link, especially when the exposure is rare or specific. - Cohort studies establish **temporal relationship** (exposure precedes disease) and can demonstrate a **dose-response relationship**, both essential for proving causality. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time, making it difficult to determine the temporal sequence of events. - While it can identify associations, it cannot definitively establish a **cause-and-effect relationship** because it doesn't observe outcomes developing over time. *Case-control study* - A **case-control study** compares individuals with the outcome (cases) to individuals without the outcome (controls) and retrospectively looks for differences in past exposures. - While useful for studying **rare diseases** and can suggest associations, it is prone to **recall bias** regarding exposure history and cannot establish causality as definitively as cohort studies. *Randomized control trial* - A **randomized controlled trial (RCT)** involves randomly assigning participants to an intervention group or a control group and following them prospectively. - While RCTs provide the strongest evidence for causality, it would be **unethical** to intentionally expose people to a known carcinogen like dye industry chemicals for research purposes.

Q: Which study design is most effective for investigating rare adverse effects of a drug?

Case-control study. ***Case-control study*** - This design starts by identifying individuals with the **rare adverse effect (cases)** and a control group without the effect to look back for exposure to the drug. - It is efficient for studying rare outcomes because it doesn't require following a large population for a long time to observe few events. *Cohort study* - A **cohort study** follows a group of individuals exposed and unexposed to a drug forward in time to observe outcomes. - While good for common outcomes, it would require an **extremely large sample size** and a long follow-up period to observe rare adverse drug effects. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time. - This design is suitable for determining **prevalence** but cannot establish temporal relationships between drug exposure and rare adverse effects, nor is it efficient for rare outcomes. *Clinical trial/experimental study* - **Clinical trials** are primarily designed to test the efficacy and safety of new interventions, usually focusing on common adverse effects. - They are generally **not powered** or long enough to detect rare adverse events, as such events would occur in very few participants, if any.

Question 1

The variation in data is compared with another data set by:

Accepted Answer

Coefficient of variation

Answer

Standard Deviation

Answer

Standard Error of Mean

Answer

Variance

Question 2

In the context of statistical analysis, if you have the value of one variable, which coefficient would you use to predict the value of another variable?

Accepted Answer

Coefficient of regression

Answer

Coefficient of variation

Answer

Coefficient of correlation

Answer

Coefficient of determination

Question 3

Which of the following best describes the Paired T test?

Accepted Answer

Test used to assess quantitative observations before and after an intervention.

Answer

Test used for categorical data.

Answer

Test applied to compare means of two independent groups.

Answer

None of the options.

Question 4

In a screening test for DM out of 1000 population, 90 were positive. When the gold standard test was applied to the entire population, 100 were found to have the disease. Assuming all 90 screening positives were confirmed as true positives by the gold standard, calculate the sensitivity.

Accepted Answer

True positives divided by total actual positives (90%)

Answer

All positives identified by the test assumed as true positives (100%)

Answer

Underestimated true positives divided by total actual positives (80%)

Answer

Total positives identified by the test divided by total actual positives (90%)

Question 5

Which measure indicates the diagnostic power of a test to correctly identify those with a disease?

Accepted Answer

Sensitivity

Answer

Negative predictive value

Answer

Specificity

Answer

Positive predictive value

Question 6

Which of the following statements is true regarding a combined prospective-retrospective study?

Accepted Answer

Retrospective identification of cohort followed by prospective follow-up

Answer

Only prospective follow-up from current time point

Answer

Cross-sectional assessment at a single time point

Answer

Only retrospective data collection from past records

Question 7

In a community of 1,000,000 population, 105 children were born in a year, out of which 5 were stillbirths and 4 died within the first year of life. What is the Infant Mortality Rate (IMR)?

Accepted Answer

40

Answer

90

Answer

120

Answer

150

Question 8

What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

Accepted Answer

They minimize selection bias.

Answer

They can be conducted more quickly than other study types.

Answer

They are ideal for studying rare diseases.

Answer

They are generally less expensive than other study types.

Question 9

Bladder cancer can occur in those who are working in dye industry for 25 years. Which study design is most appropriate for establishing a causal relationship between dye industry work and bladder cancer?

Accepted Answer

Cohort study

Answer

Cross-sectional study

Answer

Case-control study

Answer

Randomized control trial

Question 10

Which study design is most effective for investigating rare adverse effects of a drug?

Accepted Answer

Case-control study

Answer

Cohort study

Answer

Cross-sectional study

Answer

Clinical trial/experimental study

Biostatistics — MCQs

Biostatistics — MCQs

On this page

Practice by Chapter

Want unlimited practice?